224 Ba´lint et al.
C19H19NO3P requires 340.1103; [M + Na]+
=
1
be reversed; H NMR (CDCl3) δ: 1.78 (s, 1H, NH),
found
2.43 (s, 3H, CH3C O),* 2.48 (s, 3H, C6 CH3),* 3.96
(d, J = 6.6) and 3.98 (d, J = 6.5) (2H, CH2), 6.60
(s, 1H, C4H), 7.45–7.84 (m, 10H, ArH), *may be
362.0926, C19H18NO3NaP requires 362.0922.
Dimethyl [(5-Acetyl-6-methyl-2-oxo-2H-pyran-3-
yl)amino]methylphosphonate (5a). Yield 90%; 31P
NMR δ: (CDCl3) 22.3; 13C NMR (CDCl3) δ: 19.6
(C6 CH3), 29.9 (CH3C O), 39.2 (J = 159.9, CH2),
53.5 (J = 6.8, OCH3), 107.7 (J = 2.0, C4), 117.6 (C5),
131.1 (J = 6.5, C3), 155.8 (C2 O),* 159.3 (C6),* 196.5
reversed; [M + H]+
= 382.1219, C21H21NO4P
found
requires 382.1208; [M + Na]+
= 404.1039,
found
C21H20NO4NaP requires 404.1028.
*
1
(C O), may be reversed; H NMR (CDCl3) δ: 1.25
(s, 1H, NH), 2.47 (s, 3H, CH3C O),* 2.51 (s, 3H,
C6 CH3),* 3.50 (d, J = 6.1) and 3.54 (d, J = 6.1)
(2H, CH2), 3.81 (d, J = 6.1, 6H, OCH3), 6.55 (s, 1H,
Diethyl [(5-Benzoyl-6-methyl-2-oxo-2H-pyran-3-
yl)amino]methylphosphonate (6a). Yield 61%; 31P
NMR δ: (CDCl3) 22.1; 13C NMR (CDCl3) δ: 16.5
(J = 5.8, CH2CH3), 18.5 (C6 CH3), 39.6 (J = 158.7,
CH2), 62.7 (J = 6.9, OCH2), 107.9 (J = 1.9, C4),
117.3 (C5), 128.8 (C2"),a 129.6 (C3"),a 133.0 (C3),
133.5 (C4"), 152.4 (C2 O),b 159.4 (C6),b 194.0 (C O),
a,bmay be reversed; 1H NMR (CDCl3) δ: 1.33 (t,
J = 7.0, 6H, CH2CH3), 1.71 (s, 1H, NH), 2.17 (s, 3H,
C6 CH3), 3.36 (d, J = 6.0) and 3.41 (d, J = 6.0) (2H,
CH2), 4.09–4.21 (m, 4H, OCH2), 6.20 (s, 1H, C4H),
C4H), *may be reversed; [M + Na]+
= 312.0612,
found
C11H16NO6NaP requires 312.0613.
Diethyl
[(5-Acetyl-6-methyl-2-oxo-2H-pyran-3-
yl)amino]methylphosphonate (5b). Yield 74%; 31P
NMR δ: (CDCl3) 20.9; 13C NMR (CDCl3) δ: 16.6 (J =
5.6, CH2CH3), 19.4 (C6 CH3), 29.7 (CH3C O), 39.7
(J = 159.0, CH2), 62.8 (J = 6.7, OCH2), 107.4 (J = 1.9,
C4), 117.4 (C5), 131.1 (J = 6.5, C3), 155.5 (C2 O),*
159.1 (C6),* 196.4 (C O), *may be reversed; 1H
NMR (CDCl3) δ: 1.26 (s, 1H, NH), 1.35 (t, J = 7.0,
6H, CH2CH3), 2.48 (s, 3H, CH3C O),* 2.52 (s, 3H,
C6 CH3),* 3.48 (d, J = 5.0) and 3.50 (d, J = 5.1)
7.44–7.85 (m, 5H, ArH); [M + H]+
= 380.1266,
found
C18H23NO6P requires 380.1263; [M + Na]+
=
found
402.1088, C18H22NO6NaP requires 402.1082.
5-Benzoyl-3-[(diphenylphosphinoyl)methylamino]-
6-methyl-2H-pyran-2-one (6d). Yield 97%; 31P NMR
δ: (CDCl3) 27.6; 13C NMR (CDCl3) δ: 18.6 (C6 CH3),
43.5 (J = 77.8, CH2), 108.3 (C4), 117.3 (C5), 128.9
(C2"),a 129.0 (J = 11.8, C2’),b 129.6 (C3"),a 131.2
(J = 9.3, C3’)b, 132.66 (C4’), 132.70 (C3), 133.5 (C4"),
152.7 (C2 O),c 159.3 (C6),c 194.0 (C O), a–cmay
(2H, CH2), 4.08–4.24 (m, 4H, OCH2), 6.58 (s, 1H,
*
C4H), may be reversed; [M + H]+
= 318.1111,
found
C13H21NO6P requires 318.1107; [M + Na]+
=
found
340.0930, C13H20NO6NaP requires 340.0926.
Dibutyl
[(5-Acetyl-6-methyl-2-oxo-2H-pyran-3-
yl)amino]methylphosphonate (5c). Yield 91%; 31P
NMR δ: (CDCl3) 22.1; 13C NMR (CDCl3) δ: 13.6
(CH3(CH2)3), 18.7 (CH3CH2CH2), 19.4 (C6 CH3),
29.6 (CH3C O), 32.6 (J = 5.7, CH2CH2O), 39.5 (J =
159.4, CH2), 66.5 (J = 6.9, OCH2), 107.3 (J = 1.9,
C4), 117.3 (C5), 131.0 (J = 7.1, C3), 155.4 (C2=O),*
159.1 (C6),* 196.3 (C O), *may be reversed; 1H
NMR (CDCl3) δ: 0.93 (t, J = 7.3, 6H, CH3(CH2)3),
1.32–1.47 (m, 4H, CH2), 1.55–1.72 (m, 4H, CH2),
2.17 (s, 1H, NH), 2.47 (s, 3H, CH3C O),* 2.52 (s,
3H, C6 CH3),* 3.46 (d, J = 6.2) and 3.51 (d, J = 6.2)
1
be reversed; H NMR (CDCl3) δ: 1.71 (s, 1H, NH),
2.16 (s, 3H, C6 CH3), 3.83 (d, J = 6.9) and 3.85 (d,
J = 7.0) (2H, CH2), 6.16 (s, 1H, C4H), 7.43–7.82 (m,
15H, ArH); [M + H]+
= 444.1366, C26H23NO4P
found
requires 444.1365; [M + Na]+
= 466.1184,
found
C26H22NO4NaP requires 466.1184.
REFERENCES
[1] Kabachnik, M. I.; Medved, T. Y. Dokl Akad Nauk
SSSR 1952, 83, 689–692.
(2H, CH2P), 4.05–-4.15 (m, 4H, OCH2), 6.54 (s, 1H,
*
C4H), may be reversed; [M + H]+
= 374.1734,
[2] Fields, E. K. J Am Chem Soc 1952, 74, 1528–1531.
[3] Kukhar, V. P.; Hudson, H. R. (Eds.). Aminophospho-
nic and Aminophosphinic Acids: Chemistry and Bio-
logical Activity; Wiley: Chichester, UK, 2000.
[4] Zefirov, N. S.; Matveeva, E. D. Arkivoc 2008, 1–17.
[5] Keglevich, G.; Ba´lint, E. Molecules 2012, 17, 12821–
12835.
[6] Kafarski, P.; Lejczak, B. Curr Med Chem Anti-Cancer
Agents 2001, 1, 301–312.
[7] Mucha, A.; Kafarski, P.; Berlicki, L. J Med Chem
2011, 54, 5955–5980.
found
C17H29NO6P requires 374.1733; [M + Na]+
=
found
396.1550, C17H28NO6NaP requires 396.1552.
5-Acetyl-3-[(diphenylphosphinoyl)methylamino]-
6-methyl-2H-pyran-2-one (5d). Yield 98%; 31P NMR
δ: (CDCl3) 28.2; 13C NMR (CDCl3) δ: 19.4 (C6 CH3),
29.7 (CH3C O), 44.2 (J = 78.6, CH2), 108.0 (C4),
117.4 (C5), 129.0 (J = 11.8, C2’),a 130.6 (J = 99.3,
C1’), 131.2 (J = 9.4, C3’),a 132.67 (C4’), 132.70 (C3),
155.7 (C2 O),b 159.0 (C6),b 196.4 (C O), a,bmay
[8] Grembecka, J.; Mucha, A.; Cierpicki, T.; Kafarski, P.
J Med Chem 2003, 46, 2641–2655.
Heteroatom Chemistry DOI 10.1002/hc